跳至主要内容
临床试验/NCT01222377
NCT01222377终止不适用

Endoscopic Breast Surgery Feasibility Study

University of Southern California2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
2
主要终点
To estimate the surgical complication rate among all patients having EBS and the local recurrence rate among patients with breast cancer

研究概览

简要总结

RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.

详细描述

PRIMARY OBJECTIVES: I. To determine the surgical complication rate in patients undergoing EBS for benign or malignant disease and the 5-year local recurrence rate following endoscopic breast surgery among subjects undergoing EBS for breast cancer at USC. SECONDARY OBJECTIVES: I. To evaluate the safety, breast cosmesis and patient quality of life following EBS. OUTLINE: Patients undergo endoscopic breast surgery. After completion of study treatment, patients are followed up every 6 months for 5 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Breast cancer or prophylactic mastectomy requiring axillary nodal staging
  • Breast disease (e.g., fibroadenoma, ADH)
  • Ability to read and/or comprehend consent form and questionnaires
  • Ability to follow-up per protocol
  • Not pregnant or breastfeeding

排除标准

  • Pregnant or breastfeeding
  • Evidence of chest wall or skin* involvement
  • NOTE: *may be endoscopy-assisted

结局指标

主要结局

To estimate the surgical complication rate among all patients having EBS and the local recurrence rate among patients with breast cancer

时间窗: 5 years

次要结局

  • To evaluate the safety, breast cosmesis and patient quality of life following EBS(After completion of study treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验